Acquired Thrombotic Thrombocytopenic Purpura Following Inactivated COVID-19 Vaccines: Two Case Reports and a Short Literature Review.

Ben Saida, Imen; Maatouk, Iyed; Toumi, Radhouane; Bouslama, Emna; Ben Ismail, Hajer; Ben Salem, Chaker; Boussarsar, Mohamed

Ben Saida, Imen; Maatouk, Iyed; Toumi, Radhouane; Bouslama, Emna; Ben Ismail, Hajer; Ben Salem, Chaker; Boussarsar, Mohamed.

Afiliación

Ben Saida I; Medical Intensive Care Unit, Faculty of Medicine of Sousse, University of Sousse, Sousse 4000, Tunisia.
Maatouk I; Research Laboratory Heart Failure, LR12SP09, Farhat Hached University Hospital, University of Sousse, Sousse 4000, Tunisia.
Toumi R; Medical Intensive Care Unit, Faculty of Medicine of Sousse, University of Sousse, Sousse 4000, Tunisia.
Bouslama E; Medical Intensive Care Unit, Faculty of Medicine of Sousse, University of Sousse, Sousse 4000, Tunisia.
Ben Ismail H; Research Laboratory Heart Failure, LR12SP09, Farhat Hached University Hospital, University of Sousse, Sousse 4000, Tunisia.
Ben Salem C; Department of Hematology, Faculty of Medicine of Sousse, University of Sousse, Sousse 4000, Tunisia.
Boussarsar M; Department of Hematology, Faculty of Medicine of Sousse, University of Sousse, Sousse 4000, Tunisia.

Vaccines (Basel) ; 10(7)2022 Jun 24.

Article en En | MEDLINE | ID: mdl-35891176

Palabras clave

COVID-19; purpura; safety; thrombotic thrombocytopenic; vaccines

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 4_covid_19 / 6_haemoglobinopathies_hemolytic_anaemias / 6_other_blood_disorders Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Túnez

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google